Third Quarter Highlights Contract revenues of $1.136 billion; 4.6% organic growth year over yearNon-GAAP Adjusted EBITDA of $166.8 million, or 14.7% of contract revenuesNet Income of.
Second Quarter Highlights Contract revenues of $1.042 billion; 7.1% growth year over yearNon-GAAP Adjusted EBITDA of $130.8 million, or 12.6% of contract revenuesNet Income of $60.2 million, or.
While the top- and bottom-line numbers for Ligand (LGND) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.